Spring Venture Ltd Oriental serves as Executive at Terns Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Spring Venture Ltd Oriental has executed 3 insider transactions totaling $8.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 23, 2022 involved selling 166,666 shares valued at $916.7K.
Spring Venture Ltd Oriental currently holds 529,762 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Spring Venture Ltd Oriental has been a net seller of TERN stock. They have purchased $0 and sold $8.3M worth of shares.
Spring Venture Ltd Oriental's most recent insider trade was on Nov 23, 2022, when they sold 166,666 shares at $5.50 per share.
Get notified when new Form 4 filings are submitted
| $5.50 |
| Discretionary |
| Nov 23, 2022 | TERN | $5.5M | Sale | 1,000,000 | $5.50 | Discretionary |